Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer
- PMID: 24179160
- PMCID: PMC3954647
- DOI: 10.1126/science.1245627
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer
Abstract
The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo-electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.
Figures
Similar articles
-
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.PLoS Pathog. 2018 May 10;14(5):e1006986. doi: 10.1371/journal.ppat.1006986. eCollection 2018 May. PLoS Pathog. 2018. PMID: 29746590 Free PMC article.
-
Crystal structure of a soluble cleaved HIV-1 envelope trimer.Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31. Science. 2013. PMID: 24179159 Free PMC article.
-
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.Acta Crystallogr D Biol Crystallogr. 2015 Oct;71(Pt 10):2099-108. doi: 10.1107/S1399004715013917. Epub 2015 Sep 26. Acta Crystallogr D Biol Crystallogr. 2015. PMID: 26457433 Free PMC article.
-
Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review.J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25797. doi: 10.1002/jia2.25797. J Int AIDS Soc. 2021. PMID: 34806305 Free PMC article. Review.
-
The HIV glycan shield as a target for broadly neutralizing antibodies.FEBS J. 2015 Dec;282(24):4679-91. doi: 10.1111/febs.13530. Epub 2015 Oct 23. FEBS J. 2015. PMID: 26411545 Free PMC article. Review.
Cited by
-
Cryo-electron microscopy in the study of virus entry and infection.Front Mol Biosci. 2024 Jul 24;11:1429180. doi: 10.3389/fmolb.2024.1429180. eCollection 2024. Front Mol Biosci. 2024. PMID: 39114367 Free PMC article. Review.
-
HIV-1-envelope trimer transitions from prefusion-closed to CD4-bound-open conformations through an occluded-intermediate state.bioRxiv [Preprint]. 2024 Jul 17:2024.07.15.603531. doi: 10.1101/2024.07.15.603531. bioRxiv. 2024. PMID: 39071380 Free PMC article. Preprint.
-
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines.NPJ Vaccines. 2024 Apr 6;9(1):74. doi: 10.1038/s41541-024-00862-8. NPJ Vaccines. 2024. PMID: 38582771 Free PMC article.
-
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base.iScience. 2024 Jan 11;27(2):108877. doi: 10.1016/j.isci.2024.108877. eCollection 2024 Feb 16. iScience. 2024. PMID: 38318357 Free PMC article.
-
Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.J Virol. 2024 Feb 20;98(2):e0174223. doi: 10.1128/jvi.01742-23. Epub 2024 Jan 9. J Virol. 2024. PMID: 38193694 Free PMC article.
References
-
- Kwong PD, Mascola JR, Nabel GJ. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat Rev Immunol. 2013;13:693. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials